(Q38046586)

27 August 2017

title

Triple-negative breast cancer: epidemiological considerations and recommendations (English)

1 reference

triple-negative breast cancer

27 August 2017

1 reference

1 reference

1 reference

1

1 reference

27 August 2017

publication date

1 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

23 Suppl 6

1 reference

27 August 2017

page(s)

vi7-12

1 reference

The globalisation of cancer

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

How basal are triple-negative breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Triple-negative breast cancer and obesity in a rural Appalachian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Triple-negative breast cancers are increased in black women regardless of age or body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

The epidemiology of triple-negative breast cancer, including race

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Risk factors for triple-negative breast cancer in women under the age of 45 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Emerging breast cancer epidemic: evidence from Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

Mammary development meets cancer genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS187

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS187

1 reference

27 August 2017

1 reference